C
oronary reperfusion improves ventricular function and survival after infarction, 1,2 but concern persists that damaged but otherwise viable myocytes may undergo necrosis during reperfusion. 3, 4 Although interventional studies with scavengers of oxygen radicals, 5, 6 inhibition or removal of neutrophil leukocytes, 7, 8 and administration of adenosine 9 suggest that myocardial necrosis does occur during reperfusion, direct evidence has been lacking. Sequential measurements of viability, using a marker of basic cellular metabolism, are required to address this question. Radionuclide-labeled 2-deoxyglucose is used as a tracer of glucose uptake and phosphorylation in brain 10 and heart. 11 Although rapidly phosphorylated by hexokinase, 12 2-deoxyglucose is not a substrate for further glycolytic metabolism and is trapped in the cell. 13 The rate constant for phosphorylation of 18 F-2-deoxyglucose by hexokinase (k 3 ) is correlated with glucose metabolism in the reperfused myocardium. 14 We used 2-deoxyglucose for sequential measurements of viability in reperfused myocardium, with injection of 14 C-2-deoxyglucose immediately after reperfusion and 18 F-2-deoxyglucose 3 hours later. Uptake of 2-deoxyglucose was compared with histochemical and ultrastructural evidence of reversible and irreversible myocardial injury and correlated with collateral blood flow during ischemia to differentiate lethal injury occurring during ischemia from that occurring during reperfusion.
Methods
Thirty-three mongrel dogs of either sex (weight, 20 to 27 kg) were studied after an overnight fast. The dogs were anesthetized with sodium thiamylal (12.5 mg/kg IV) followed by chloralose (14 mg/kg IM) in urethane (136 mg/kg). Polyvinyl catheters were placed in the right femoral artery and vein for reference sampling of microspheres and administration of intravenous fluids, respectively. After left thoracotomy, a catheter was placed in the left atrium for microsphere injections and a catheter-tip pressure transducer (5F, Millar Instruments) was advanced to the left ventricle from the left atrium. An inflatable occluder was placed around the proximal LAD. Hemodynamics were continuously recorded on chart paper (Gould Instruments).
Myocardial Distribution and Retention of 2-Deoxyglucose
Because 14 C-2-deoxyglucose and 18 F-2-deoxyglucose are not structurally identical, the distribution of the two tracers in reperfused myocardium was studied in three dogs. After 90 minutes of LAD occlusion, the dogs received simultaneous intravenous 14 C-2-deoxyglucose (25 Ci; specific activity, 59 mCi/mmol; Sigma) and 18 F-2-deoxyglucose (0.25 to 1.5 mCi; Division of Nuclear Medicine, Johns Hopkins Medical Institutions). Tracers were injected after 5 minutes of reperfusion in one dog, after 15 minutes in the second, and after 3 hours in the third. At 60 minutes after tracer injection, the LAD was reoccluded and monastral blue dye injected into the left atrium to define the ischemic region. Multiple (nϭ30 to 40) biopsies (30 to 85 mg wet wt) were obtained from reperfused myocardium for counting of 14 C and 18 F activities. Retention of 14 C-2-deoxyglucose in reperfused myocardium was studied in three other dogs. After 90 minutes of LAD occlusion and 5 minutes of reperfusion, 14 C-2-deoxyglucose was given intravenously. Transmural biopsies (15 to 30 mg wet wt) were taken in triplicate from LAD and circumflex artery territories by biopsy drill at 1, 2, and 3 hours after tracer injection. The heart was arrested after 4 hours and further biopsies taken. The biopsies were weighed and counted for 14 C activity. In two other dogs, myocardial retention of 18 F-2-deoxyglucose was compared with myocardial blood flow during ischemia and reperfusion. The LAD was occluded for 90 minutes and blood flow measured by radionuclide-labeled 15-m microspheres ( 141 Ce, 113 Sn, 46 Sc; Du Pont Co) injected into the left atrium, with reference sampling from the right femoral artery, at 10 minutes before reperfusion. After 10 minutes reperfusion, 18 F-2-deoxyglucose was injected intravenously. A biopsy was excised by scalpel from reperfused myocardium 35 minutes later and divided into endocardial and epicardial halves. After 3 hours of reperfusion, blood flow was measured with microspheres before repeat biopsy of reperfused myocardium and the normal circumflex artery territory. Samples were weighed and counted for 18 F activity and microspheres.
Comparison of 18 F-2-Deoxyglucose Uptake With Histology
In seven dogs the LAD was occluded for 90 minutes and myocardial blood flow measured by microspheres at 10 minutes before reperfusion. After 5 minutes of reperfusion, 18 F-2-deoxyglucose was injected intravenously, followed by a second microsphere injection. After 35 minutes of reperfusion, the heart was arrested by intravenous potassium chloride, excised, and sectioned into short-axis slices. Multiple transmural sections from normal and reperfused regions were divided into fifths from endocardium to epicardium (30 to 100 mg wet wt per sample). Samples were randomly selected from the control and reperfused myocardium in each dog for electron microscopy. A small section of each sample was immersed in cold (4°C) 3% glutaraldehyde in 0.1 mol/L cacodylate buffer, pH 7.4, and kept in fixative at 4°C for 24 hours before rinsing in 0.1 mol/L cacodylate buffer (with saccharose added, pH 7.4) and storage at 4°C before examination. The remainder of the sample was counted for 18 F activity and microspheres. Operators studied all samples by light and electron microscopy, without knowledge of sample location or regional blood flow. Samples were embedded in epon with the use of a Wakura automatic tissue processor, after fixation in 2% osmic acid anhydride, dehydration in an ethanol series, and substitution by propylenoxide. Semithin (1 to 2 m) sections were stained with toluidine blue. Artifact-free areas were selected for preparation of thin sections (50 to 60 nm), which were attached to uncoated copper grids, stained with uranyl acetate and lead citrate, and viewed in a Phillips EM 300-electron microscope. For each myocardial sample, 30 to 40 micrographs were examined according to previously established criteria. 15, 16 Reversible injury was identified by absence of contraction bands, an intact sarcolemma, absence of mitochondrial amorphous densities, and absence of nuclear clearing and shrinkage. Irreversible injury was identified by the presence of amorphous densities, matrix clearing and/or cristae breakage in the mitochondria, clearing and shrinkage of nuclei, and/or disruption of the sarcolemma. A sample was deemed to have suffered irreversible injury if Ͼ50% of the micrographs from that sample showed evidence of irreversible injury.
Sequential Measurements of 2-Deoxyglucose Uptake in Reperfused Myocardium
Myocardial uptake of 2-deoxyglucose after 5 minutes and 3 hours of reperfusion was studied in 18 dogs in which the LAD was occluded for 90 minutes before free reperfusion was allowed. Myocardial blood flow was measured by microspheres 10 minutes before reperfusion and 10 minutes and 3 hours after reperfusion. After 5 minutes of reperfusion, 14 C-2-deoxyglucose (25 Ci) was injected intravenously and after 3 hours of reperfusion, 18 F-2-deoxyglucose (Ϸ1 mCi; range, 0.25 to 2 mCi) was injected intravenously. The 18 F-2-deoxyglucose was used as the second tracer because of the short half-life of 18 F. One hour after injection of 18 F-2-deoxyglucose, the fluorescent dye thioflavine-S (2% solution) was injected into the left atrium to define no-reflow zones. Two minutes later the LAD was reoccluded and monastral blue dye (20 mL) was injected into the left atrium to define the ischemic risk region. The heart was then arrested with potassium chloride and excised for tissue sampling and measurement of infarct size.
The left ventricle was isolated and sectioned into five transverse slices (8 to 10 mm thick), which were weighed and examined under ultraviolet light to define no-reflow zones (absent thioflavin-S fluorescence). Endocardial and epicardial surfaces of each myocardial slice and borders of the ischemic region and the no-reflow zones were traced on acetate sheets. Transmural sections were excised at multiple sites in the LAD and circumflex territories of each heart and divided into fifths (70 to 100 mg wet wt per sample). A total of 60 to 70 samples were obtained from each heart, and sample sites were recorded on the acetate sheets. The myocardial slices were incubated in 2,3,5-TTC solution at 37°C for 30 minutes to differentiate infarcted myocardium (absent or negative TTC staining) from salvaged myocardium (brick-red or positive TTC staining). [17] [18] [19] The borders of infarct and noninfarct regions were traced on the corresponding acetate sheets and planimetered to measure the ischemic risk region, infarct region, and no-reflow region.
Radionuclide Measurements
Myocardial samples were weighed and counted with flow reference samples and radionuclide standards in an NaTl crystal well counter (Packard 5986) set for photopeaks of 18 F, 141 Ce, 113 Sn, and 46 Sc. Decay-corrected counts were corrected for crossover between radionuclides and blood flow calculated according to standard methods. 20 Samples were then solubilized (Protosol, Du Pont) and incubated at 50°C for 48 hours, before addition of 10 mL scintillation cocktail (EconoFluor, Du Pont) and liquid scintillation counting (Packard Tri-Carb 2660) for 14 C activity. To eliminate any error in 14 C measurement due to the presence of gamma emitters in the samples, calibration curves were determined for beta activity observed in the presence of 141 Ce, 113 Sn, and 46 Sc. After counting for 18 F activity, tissue samples were counted twice in both gamma and beta counters at an interval of 4 weeks, with decay correction for each nuclide. Beta count activity due to the gamma emitters was then subtracted from total observed beta counts to derive the true 14 C count activity. Because reperfusion of lethally injured myocardium is associated with tissue edema and an increase in tissue wet weight of Ϸ25% during the first few hours, 21 radionuclide count data for microspheres and 14 C-2-deoxyglucose (injected during ischemia or early reperfusion) in samples from the infarct region were corrected to allow for a 25% increase in tissue wet weight during reperfusion.
The measure of viability of a myocardial sample is the phosphorylation rate of 2-deoxyglucose. When the time from tracer injection to sampling exceeds 30 minutes, the amount of nonmetabolized tracer in the sample approaches zero. 22 With the use of a three-compartment model of myocardial uptake and phosphorylation of 2-deoxyglucose, 14 
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LAD ϭ left anterior descending coronary artery TTC ϭ triphenyl-tetrazolium chloride PET ϭ positron emission tomography the overall reaction rate in the sample of interest R i can be described as:
where BGϭblood glucose level; K 1 i ϭrate of transport of 2-deoxyglucose into myocyte from plasma; k 2 i ϭrate of reverse transport of 2-deoxglucose from myocyte to plasma; and k 3 i ϭrate of phosphorylation of 2-deoxyglucose by hexokinase. Because the lumped constant (LC) and arterial input function are the same for all samples in each heart, the ratio of reaction rates in two samples can be calculated as the ratio of tracer activities:
where C i Tϭtracer content in sample of interest; and C r Tϭtracer content in reference sample. The rate constants of 2-deoxyglucose uptake and phosphorylation in reperfused canine myocardium have been previously described, 14 allowing calculation of k 3 i for the infarct region. The previous data show that k 3 increases in normal myocardium after an infarct, but k 3 in salvaged postischemic myocardium remains comparable to that of the control state. Therefore, the salvaged (TTC-positive) myocardium was used as the reference region. For all samples from reperfused myocardium the rate constants used were
ϭ0.87 min -1 . For samples from normal myocardium, the rate constants used were
ϭ1.44 min -1 .
14
The same rate constants were used for calculation of k 3 for 14 C-and 18 F-2-deoxyglucose.
Statistics
The proportion of samples in reperfused myocardium that were viable with 14 C-2-deoxyglucose (early reflow) was compared with the proportion that were viable with 18 F-2-deoxyglucose (late reflow) by 2 analysis. Hemodynamic and regional myocardial blood flow measurements during ischemia and reperfusion were compared by ANOVA. 23 Myocardial 2-deoxyglucose contents were compared between control and postischemic regions in each dog by ANOVA. The proportions of samples that appeared to undergo necrosis during the ischemic period, or necrosis during reperfusion, or remained viable were compared with collateral blood flow by regression analysis. Results are reported as meanϮSD, and a value of PϽ.05 is described as significant.
Results

Uptake and Distribution of 2-Deoxyglucose
The distribution of 14 C-2-deoxyglucose and 18 F-2-deoxyglucose in reperfused myocardium, after simultaneous injection of both tracers, is shown in Fig 1. Data are shown for 108 myocardial samples from three dogs. The slope (0.93) reflects slightly lower 18 F-2-deoxyglucose uptake after 5 minutes of reperfusion, but neither the group regression nor individual regressions differed from the line of identity, indicating that tissue distributions and retention of the tracers were equivalent. Retention of 14 C-2-deoxyglucose in normal and reperfused myocardium is shown for another three dogs in Fig 1. One hour after injection, mean 14 C-2-deoxyglucose content in reperfused myocardium was half of that in normal myocardium (PϽ.01). Myocardial count activities were similar to those in subsequent experiments. During 3 hours after injection, there was no significant change in mean 14 C activity in normal or reperfused myocardium. Biopsies obtained 4 hours after reperfusion had 14 C activity similar to that of biopsies taken after 1 hour. In the other two dogs, which had both flow and 18 F-2-deoxyglucose uptake measurements, samples were grouped according to myocardial blood flow. Samples with severe ischemia (collateral flow Ͻ10% of control) and impaired reperfusion (flow Ͻ40% of control), which are likely to have the most severe necrosis, had similar 18 F-2-deoxyglucose content after 35 minutes (40% of control) and after 3 hours (41% of control) reperfusion. These data show that radiolabeled 2-deoxyglucose, injected during early reperfusion, is retained over 4 hours in reperfused myocardium.
Comparison of 2-Deoxyglucose Uptake With Histopathology
The uptake of 18 F-2-deoxyglucose in normal and reperfused myocardium was compared with electron microscopy findings in seven dogs. Blood flow to control (1.45Ϯ0.54 mL/min per gram) and reperfused (1.54Ϯ0.34 mL/min per gram) myocardium was similar, but 18 F-2-deoxyglucose content was less in reperfused myocardium (61 465Ϯ30 328 counts/min per gram) than in the control region (106 760Ϯ71 013 counts/ min per gram, PϽ.05). Samples were randomly selected from control (nϭ6) and reperfused (nϭ28) regions. All control samples had the ultrastructural features of viable myocardium ( Fig 2A) . Among samples from reperfused myocardium, 8 manifested reversible ischemic injury (Fig 2B) and 20 had irreversible injury (Fig 2C) . The mean k 3 for these samples were 0.320Ϯ0.152 min -1 for control, 0.194Ϯ0.070 min -1 for reversible injury, and 0.098Ϯ0.055 min -1 for irreversible injury (PϽ.01 versus reversible injury). The individual k 3 values were compared with the electron microscopy findings to determine which value of k 3 was the best discriminator between reversible and irreversible injury (Fig 3) . A value of k 3 ϭ0.125 min -1 appeared to be the best indicator of viability (sensitivityϭ93%, specificityϭ85%, predictive accuracyϭ88%). If a value of k 3 ϭ0.100 min -1 was used, specificity decreased to 60%, and if a value of k 3 ϭ0.150 min -1 was used, sensitivity decreased to 86%. For the subsequent serial studies of 2-deoxyglucose uptake, samples with k 3 Ͻ0.125 min -1 were considered nonviable and those with k 3 Ն0.125 min -1 were considered viable.
Serial Studies of 2-Deoxyglucose Uptake in Reperfused Myocardium
Among 18 dogs included in the group, two had ventricular fibrillation shortly after reperfusion and were not resuscitated. Four dogs with collateral blood flows Ͼ30% control flows and no evidence of infarction on TTC staining were excluded from analysis. Data are reported for 12 dogs that completed 90 minutes of ischemia and 4 hours of reperfusion with TTC evidence of infarction. Heart rate did not change from before ischemia (136Ϯ19 bpm) to 3 hours of reperfusion (135Ϯ28 bpm), but mean arterial pressure was lower during ischemia (92Ϯ22 mm Hg) than before ischemia (102Ϯ24 mmHg) or after 3 hours of reperfusion (102Ϯ20 mm Hg, PϽ.05 versus ischemia). Blood flow in the circumflex territory was 1.07Ϯ0.57 mL/min per gram after 5 minutes of reperfusion and 1.03Ϯ0.55 mL/min per gram after 3 hours. Collateral flow during LAD occlusion was 0.07Ϯ0.04 mL/min per gram, increasing to 1.19Ϯ0.34 mL/min per gram during early reperfusion. After 3 hours, flow in the LAD myocardium was 0.68Ϯ0.23 mL/min per gram (PϽ.05 versus early reperfusion). Collateral flow to the TTC-positive region was greater than flow to the TTC-negative region (PϽ.01) ( Table 1) . Blood flow was reduced in the no-reflow zones, but there was no other difference in flow between TTC-negative and TTC-positive regions during reperfusion. A total of 850 myocardial samples were examined (340 from the control circumflex territory and 510 from the reperfused LAD territory). Among samples from reperfused myocardium, 237 were from TTC-negative regions, including 58 from the no-reflow zone, and 164 were from TTC-positive regions. There were 109 samples from borders of TTC-negative and TTC-positive myocardium, which were not included in the data analysis. Among the 401 samples from reperfused myocardium, the 18 F-2-deoxyglucose k 3 threshold of 0.125 min This heart had reduced 14 C-2-deoxyglucose uptake in TTCnegative myocardium after 5 minutes of reperfusion (Fig 4, A and  B) . In TTC-negative samples the k 3 for 14 C-2-deoxyglucose was 0.082Ϯ0.019 min -1 , and all but one of these samples had k 3 Ͻ0.125 min -1 , indicating necrosis by 5 minutes after reperfusion. The same TTC-negative samples all had k 3 Ͻ0.125 min -1 for 18 F-2-deoxyglucose (Fig 4, C and D) , with k 3 ϭ0.067Ϯ0.015 min -1 (NS versus 14 C-2-deoxyglucose). Eight samples from no-reflow regions all had k 3 Ͻ0.125 min -1 at both early and late reperfusion. The data in this heart are consistent with irreversible injury occurring during ischemia.
Data for a different heart are shown in Fig 5. There was avid uptake of 14 C-2-deoxyglucose during early reperfusion in both TTC-positive and TTC-negative regions (Fig 5A) . The calculated k 3 for 14 C-2-deoxyglucose in the TTC-negative region was 0.228Ϯ0.077 min -1 . All samples in the TTC-negative region had k 3 Ͼ0.125 min -1 , indicating viability at 5 minutes of reperfusion (Fig 5B) . After 3 hours of reperfusion the k 3 for 18 F-2-deoxyglucose in the same TTC-negative samples was 0.057Ϯ0.016 min -1 (PϽ.001 versus 14 C-2-deoxyglucose), and all TTC-negative samples had k 3 Ͻ0.125 min -1 , indicating irreversible injury by the time of 18 F-2-deoxyglucose injection (Fig 5, C and D) . The data in this heart are consistent with the occurrence of necrosis during the reperfusion period.
The 2-deoxyglucose k 3 values in TTC-positive and TTCnegative myocardium are summarized for the group in Table  2 . In the no-reflow region, k 3 after 5 minutes of reperfusion was 0.096Ϯ0.027 min -1 and after 3 hours 0.060Ϯ0.023 min -1 (NS). All but 2 of these samples were classified as nonviable after 5 minutes and all were nonviable after 3 hours of reperfusion. In the TTC-negative region, k 3 decreased from 0.184Ϯ0.070 min -1 after 5 minutes of reperfusion to 0.077Ϯ0.032 min -1 (PϽ.0001) after 3 hours. After 5 minutes, 117 of these 179 samples were viable according to the k 3 threshold, but after 3 hours only 4 were viable (PϽ.0001). In the TTC-positive region, mean k 3 after 5 minutes (0.170Ϯ0.087 min -1 ) and after 3 hours (0.170Ϯ0.056 min -1 ) were similar, and 155 of these 164 samples were viable. Among 237 samples from no-reflow and TTC-negative infarct regions, 119 (50.2%) were viable at the time of 14 C-2-deoxyglucose injection, but only 4 (1.7%) were viable at the time of 18 , almost no samples in the no-reflow zones were classified as viable by 14 C-2-deoxyglucose or 18 F-2-deoxyglucose. In TTC-positive myocardium, the proportions of samples classified as viable by 14 C-2-deoxyglucose and 18 F-2-deoxyglucose were similar, whichever value of k 3 was used. In TTC-negative myocardium, there was a marked difference between the proportions of samples classified as viable by 14 C-2-deoxyglucose and those classified as viable by 18 F-2-deoxyglucose.
Ischemic Necrosis, Reperfusion Necrosis, and Infarct Size
The ischemic risk region occupied 30.0Ϯ4.0% of the left ventricle. The mean infarct size was 37.6Ϯ21.0% of the risk region (range, 5.7% to 68.3%), and the mean size of the no-reflow region was 8.3Ϯ7.7% of the risk region. Total infarct size was inversely related to collateral blood flow during ischemia (rϭ Ϫ.87), and the extent of the no-reflow zone was also inversely related to collateral blood flow (rϭ Ϫ.64).
The proportion of anatomic infarct size due to necrosis during ischemia or reperfusion in each dog was calculated from the number of infarct samples that were nonviable by both 14 C-2-deoxyglucose and 18 F-2-deoxyglucose (ischemic necrosis) or viable by 14 C-2-deoxyglucose but nonviable by 18 F-2-deoxyglucose (reperfusion necrosis) for that particular dog. The proportions of infarct size due to ischemic or reperfusion necrosis varied according to the level of collateral blood flow (Fig 7) . The four dogs with the lowest collateral blood flow (2.8Ϯ1.1% of control flow) had the largest infarcts (54Ϯ7% of risk region) and in these dogs 86Ϯ12% of the infarct samples were irreversibly injured by 5 minutes of reperfusion. The four dogs with intermediate collateral flows (4.8Ϯ0.9% of control) had an infarct size of 46Ϯ15% of risk region, but only 30Ϯ23% of infarct samples were irreversibly injured by 5 minutes of reperfusion. In contrast, the four dogs with the highest collateral flows (12.7Ϯ3.1% of control) had small infarcts (13Ϯ10% of risk region) and only 7Ϯ7% of infarct samples were nonviable by 5 minutes of reperfusion. As collateral blood flow increased, the proportion of infarction due to irreversible injury during reperfusion increased.
Discussion
This study examined changes in viability of reperfused myocardium. In salvaged myocardium, uptakes of 14 C-2-deoxyglucose during early reperfusion and 18 F-2-deoxyglucose 3 hours later were similar and above a threshold of viability. In samples from severely injured no-reflow regions, both 14 C-2-deoxyglucose and 18 F-2-deoxyglucose uptakes were below the viability threshold. In most samples from the infarct region, 14 C-2-deoxyglucose uptake during early reperfusion was above the viability threshold, but 3 hours later uptake of 18 F-2-deoxyglucose in the same samples was reduced to levels associated with irreversible injury, consistent with the occurrence of myocyte necrosis during reperfusion. Regions with low collateral flows had nearly complete loss of viability by the end of ischemia, but regions with higher collateral flows appeared to undergo necrosis during reperfusion.
Myocardial Viability and 2-Deoxyglucose
The tracer 18 F-2-deoxyglucose is widely used as a viability marker in clinical studies with PET. 24 The phosphorylated tracer accumulates within myocytes, reaching steady state by 60 minutes, 25 because dephosphorylation is slow and alternate metabolic pathways are limited. 26 Myocardial uptake of 2-deoxyglucose depends on tracer delivery and kinetics of 2-deoxyglucose transport and phosphorylation. We calculated k 3 , the rate constant for 2-deoxyglucose phosphorylation, in individual myocardial samples, using parameters derived from PET studies of reperfused infarcts in canine hearts.
14 The values of k 3 calculated for normal, salvaged, and infarcted myocardium in this study are similar to the previous PET data. To Figure 4 . Uptake of 14 C-2-deoxyglucose and 18 F-2-deoxyglucose in reperfused myocardium of one heart. The TTC-negative region had low uptake of both 14 C-2-deoxyglucose (A) and 18 F-2-deoxyglucose (C). The TTC-negative samples were below the viability threshold (k 3 ϭ0.125 minutes -1 shown as dashed line) for both 14 C-2-deoxyglucose (B) and for 18 F-2-deoxyglucose (D), suggesting that necrosis was complete by the end of the ischemic period.
define an appropriate value of k 3 as a marker of viability, we compared tissue k 3 with ultrastructural appearance and histochemical staining of reperfused myocardium. Myocardial samples with an ultrastructural pattern of irreversible injury, after 1 hour of reperfusion, had k 3 Ͻ0.125 min -1 , but samples showing reversible injury had k 3 Ն0.125 min -1 . Similarly, samples that were necrotic by TTC stain after 4 hours of reperfusion had k 3 Ͻ0.125 min -1 , but samples that were viable by TTC stain had k 3 Ն0.125 min -1 . The lowest k 3 values were found in the no-reflow regions with the most severe ischemic injury. Small differences in predictive accuracy of k 3 ϭ0.125 min -1 for detection of viability compared with electron microscopy or TTC stain reflect different numbers of samples in each comparison. It should be noted that this threshold may not be universally applicable, particularly for clinical PET studies when patients are given a glucose load.
The k 3 in the reference region and the value of the viability threshold might change during reperfusion, but our pathology comparisons indicate the same viability threshold at 35 minutes and at 4 hours after reperfusion. There was no systematic change in k 3 in the normal myocardium in this study and the previous PET study 14 found no change in k 3 in salvaged myocardium. The proportion of samples deemed viable by 14 C-2-deoxyglucose and 18 F-2-deoxyglucose in TTC-positive myocardium were the same across a wide range of k 3 values. To avoid any bias related to selection of the threshold value of k 3 , we determined the number of samples that were viable in the infarct region according to a wide range of threshold values of k 3 . Irrespective of the k 3 threshold used, many samples from the TTC-negative infarct region, which were viable at the time of 14 C-2-deoxyglucose injection after 5 minutes of reperfusion, were nonviable by the time of 18 F-2-deoxyglucose injection 3 hours later.
Interpretation of Findings
Approximately half of myocardial samples from the TTCnegative infarct region were apparently viable during early reperfusion, but during the next 3 hours exhibited a decrease in 2-deoxyglucose phosphorylation to the levels found in necrotic myocardium from the no-reflow zone. This observation is consistent with the occurrence of myocardial necrosis during reperfusion, but several other possible interpretations should be examined. Loss of 18 F-2-deoxyglucose during late reperfusion is unlikely to account for the observed differences in myocardial 2-deoxyglucose content between 5 minutes and 3 hours of reperfusion. First, our initial experiments showed that myocardial content of 2-deoxyglucose was largely unchanged during 4 hours of reperfusion. Second, if 18 F-2-deoxyglucose were lost from necrotic myocytes, then 14 C-2-deoxyglucose would also be lost. Third, increased metabolism of 18 F-2-deoxyglucose-phosphate is unlikely, as the rate constant for dephosphorylation remains an order of magnitude below k 3 during reperfusion.
14 Impaired delivery of 18 F-2-deoxyglucose to the infarct region after 3 hours of reperfusion is also unlikely to account for our findings. Blood flow to the infarct zone was mildly reduced after 3 hours, but mean flows in the TTC-negative and TTC-positive regions were similar, and myocyte uptake of 18 F-2-deoxyglucose at steady state is independent of blood flow. Reperfusion of infarcted myocardium is associated with myocyte swelling and interstitial edema. 21 The true uptake of 14 C-2-deoxyglucose during early reperfusion might be underestimated when the sample is weighed after 4 hours. This error would underestimate the calculated k 3 for early reperfusion but could not explain the differences in k 3 found in this study. Correction for tissue edema in the infarcted myocardium was used in this study, but even in the absence of any such correction, 60% of samples from TTC-negative myocardium were viable after 5 minutes of reperfusion, with k 3 Ͼ0.125 min -1 for 14 C-2-deoxyglucose. Reperfusion of irreversibly injured myocytes is associated with contraction bands, cell swelling, and sarcolemmal disruption. 27, 28 Such cells would be unlikely to accumulate 14 C-2-deoxyglucose, consistent with our finding in samples from the no-reflow zones. An increase in sarcolemmal permeability 29 leads to loss of enzymes such as creatine kinase. The reduced 18 F-2-deoxyglucose content seen during later reperfusion might reflect washout of hexokinase from necrotic myocytes, but 14 C-2-deoxyglucose would also be lost from the same myocytes. Our observations cannot be explained as an artifact of tissue edema or tracer washout. The most likely explanation is that myocytes, which were viable during early reperfusion, subsequently lost viability during the next 3 hours of reperfusion.
Irreversible Myocardial Injury During Reperfusion
Many samples from infarcted myocardium appear to have undergone necrosis after restoration of coronary blood flow. A, Samples from within the no-reflow zone. All but two samples appeared nonviable by 5 minutes of reperfusion and all were nonviable after 3 hours of reperfusion. B, Samples from the TTC-negative region. Almost all samples were necrotic after 3 hours of reperfusion, but only 35% of these samples were nonviable after 5 minutes of reperfusion. At each k 3 value, many more samples were viable at the time of 14 C-2-deoxyglucose injection than at the time of 18 F-2-deoxyglucose injection. *PϽ.05, **PϽ.01 vs 18 F-2-deoxyglucose at same k 3 . C, Samples from within the salvaged TTC-positive zone. There is no difference in viability determined by 14 C-2-deoxyglucose and 18 F-2-deoxyglucose. For the threshold of k 3 ϭ0.125 min -1 , nearly all samples are deemed viable at both 5 minutes and 3 hours after reperfusion.
Myocytes can undergo necrosis in the presence of apparently adequate coronary perfusion, as with catecholamine stress, 30, 31 loss of calcium homeostasis, 32, 33 or reoxygenation after anoxia. 34 It is also now known that myocytes may be programmed to die through the process of apoptosis. 35 Although normally a mechanism for removal of senescent cells, it is possible that apoptosis may be responsible for large scale cell loss under pathological conditions.
The small residual uptake of 2-deoxyglucose observed in infarcted myocardium may represent a few surviving myocytes, or uptake in endothelial cells or fibroblasts, but the volume of these elements is small compared with myocyte volume. Neutrophil leukocytes accumulating during reperfusion 36, 37 are a potential site of 2-deoxyglucose uptake, but leukocyte uptake of 18 F-2-deoxyglucose in reperfused myocardium is small compared with overall myocyte uptake. 38 Furthermore, any such error would result in an increase in tissue 18 F-2-deoxyglucose uptake, which is opposite to our observations. Two other studies have reported data consistent with the occurrence of irreversible myocardial injury during reperfusion. One study in rabbits, using sequential tissue staining with horseradish peroxidase and TTC, found an apparent increase in infarct size during 3 hours of reperfusion. 39 A canine study, using radionuclide-labeled antimyosin antibodies, found a progressive increase in antibody binding in reperfused myocardium, 40 which suggests lethal injury, although these observations could also be explained by increasing sarcolemmal permeability in infarcted myocytes.
This study does not define the mechanism of lethal myocardial injury occurring during reperfusion, although the concordance between the time course of reperfusion injury and neutrophil infiltration 36, 37 is compelling. Intervention studies have implicated neutrophil leukocytes in the pathogenesis of irreversible injury during reperfusion. 7, 8 Although it is possible that myocytes are "programmed" for inevitable necrosis during reperfusion, as a result of an irreversible ischemic insult, our data show that a significant proportion of samples from the infarct region are viable at the time of reperfusion and many interventional studies argue that reperfusion necrosis is not inevitable. Figure 7 . A, Relationship between collateral flow (% of normal resting flow) and infarct size due to ischemic necrosis according to 2-deoxyglucose data. B, The proportion of total infarct size due to ischemic necrosis was inversely related to collateral flow. Low collateral flows were associated with large infarcts, almost all due to ischemic necrosis. C, Relationship between collateral flow and infarct size due to reperfusion necrosis, according to 2-deoxyglucose data. Regions most likely to manifest necrosis during reperfusion were those with only mild or moderate ischemia during LAD occlusion. D, The proportion of total infarct size due to reperfusion necrosis. As collateral flows increased, a greater proportion of necrosis appeared to occur during reperfusion.
